C-XON TZ 1.125

C-XON TZ 1.125

Powerful Dual-Action Antibiotic for Advanced Infection Control
C-XON-TZ 1.125 Injection is a broad-spectrum antibiotic formulation containing Ceftriaxone 1000mg and Tazobactam 125mg. This advanced injectable combination is widely prescribed for the treatment of severe bacterial infections caused by resistant microorganisms. Ceftriaxone works by stopping bacterial growth, while Tazobactam enhances antibiotic effectiveness by blocking bacterial resistance mechanisms.

Manufactured by Citric Labs, this injectable range is trusted by healthcare professionals and is an ideal choice for hospitals, clinics, and PCD pharma franchise businesses looking for high-quality antibiotic injections.

Composition

  • Ceftriaxone Sodium IP Equivalent to Ceftriaxone – 1000mg
  • Tazobactam Sodium Equivalent to Tazobactam – 125mg
  • Dosage Form: Dry Injection / Vial
SKU: 7695731b8dad Category:

Key Benefits

  • Broad-spectrum antibacterial coverage
  • Effective against resistant bacterial strains
  • Fast and reliable infection control
  • Suitable for hospital and critical care use
  • Enhanced efficacy due to beta-lactamase inhibitor
  • Trusted injectable antibiotic formulation

Product Description

C-XON-TZ 1.125 Injection contains Ceftriaxone 1000mg and Tazobactam 125mg, a powerful broad-spectrum antibiotic combination used for treating severe bacterial infections and resistant microorganisms effectively.

Related products

Why Choose Citric Labs for PCD Pharma Franchise?

  • High-quality WHO-GMP certified products
  • Monopoly-based PCD Pharma Franchise opportunities
  • Strong product portfolio including pain management range
  • Competitive pricing & high margins
  • Reliable supply chain across India